Looking to preserve your pharmaceutical products with maximum quality and shelf-life? ✨ Our state-of-the-art facilities and advanced lyophilization services, backed by over 50 years of experience, offers unparalleled benefits: • Unmatched Quality: Advanced freeze-drying technology adhering to stringent regulatory standards • Rapid, High-Capacity Services: Efficient handling of a wide range of sterile fill & finish projects • Seamless Development to Production: Comprehensive in-house capabilities ensure a smooth transition from development to commercial scale Read our factsheet to learn more here: https://lnkd.in/d9iZgp9W #Lyophilization #fillfinish#AsepticFilling #CDMO
Recipharm
Tillverkning av läkemedel
Stockholm, Stockholm County 80 916 följare
Your innovation, delivered with certainty.
Om oss
Recipharm is an experienced, global CDMO dedicated to meeting pharmaceutical companies’ evolving needs through operational excellence, scientific know-how and customer connectivity. Headquartered in Stockholm, Sweden, we operate development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and are continuing to grow and expand our offering. Our worldwide reach paired with in-depth, localised market knowledge allows us to anticipate our customers’ needs and strengthen the support we provide to forge a healthier, more expansive and more fruitful future together. With a workforce of approximately 9,000 people, we are focused on supporting pharmaceutical companies with our full-service offering, taking products from early development through to commercial production. For over 25 years we’ve supported our customers throughout the entire product lifecycle, providing pharmaceutical expertise and managing complexity, time and time again to ensure their products are delivered with certainty.
- Webbplats
-
http://www.recipharm.com
Extern länk för Recipharm
- Bransch
- Tillverkning av läkemedel
- Företagsstorlek
- 5 001–10 000 anställda
- Huvudkontor
- Stockholm, Stockholm County
- Typ
- Privatägt företag
- Specialistområden
- Pharmaceutical contract development and manufacturing, Commercial manufacturing, Analytical chemistry, Drug substance och Drug product development
Adresser
Anställda på Recipharm
Uppdateringar
-
There is mounting pressure to deliver life-saving medications faster while maintaining high quality in the pharma industry. Presenting at TIDES USA, Chief Scientific Officer, Aaron B Cowley explored how our innovative continuous RNA manufacturing platform, CP1, leverages the integration of advanced analytics, machine learning and AI to: ✔️ Streamline production ✔️ Enhancing quality ✔️ Accelerating development Discover more about how CP1 is revolutionising the manufacturing of RNA therapies in our latest insight: https://lnkd.in/db-Usktk #RNA #ContinuousManufacturing #PAT
-
Agile. Comprehensive. Advanced. 🌟 Recipharm’s analytical experts work with you at every stage of your product lifecycle, developing robust methods in state-of-the-art facilities to deliver reliable and rapid results. Propel your project, get in touch now: https://lnkd.in/dbgVFN-W #CDMO #QualityAssurance
-
We are fully equipped and prepared to handle your pre-filled syringe (PFS) and cartridge filling project using cutting-edge technology and seamless technology transfer. Our advanced, flexible, high-speed filling lines are capable of producing millions of doses of sterile products, including biologics and biosimilars, to support your unique project. Discover more about our state-of-the-art PFS capabilities: https://lnkd.in/eWYDFZHJ #PFS #PFC #Fillfinish #Biologics
-
Are you looking for expert support in taking your molecule to market? Our goal is to streamline your product development process, reducing time and complexities to accelerate your market entry. With our extensive experience and excellent track record using we are specialized in designing and manufacturing new products by applying state-of-the-art scientific tools and fact-based decisions, which are key elements in successful product development and transfer for clinical or commercial supplies. We guarantee a smooth technology transfer process, ensuring efficient transitions into operations to ensure supply certainty. Learn how we can support your journey to market: https://lnkd.in/d3Jtm6T5 #OSD #DrugDevelopment #CDMO
-
The rise of RNA-based therapies is revolutionising medicine, offering the potential for treating a wide range of diseases. But what does this mean for drug development and manufacturing? Recently ReciBioPharm’s Head of Process Analytics and Data Science Edita B. sat down with LSKH to explore how continuous manufacturing, paired with advanced technologies like inline process analytic technologies (PAT), automation, and real-time data analytics, is poised to transform RNA therapeutics production. Dive into the full article here: https://lnkd.in/dicpSiGC #RNAtherapeutics #continuousmanufacturing #drugdevelopment #biotech
-
Thrive as Business Development Director at Recipharm! Are you a seasoned negotiator with a passion for growth? Do you thrive in a dynamic, global environment? Then this Business Development Director role at Recipharm could be perfect for you! Learn more and apply here: https://lnkd.in/dCyfJFh6
-
How do you mitigate risks and ensure a seamless, robust, and effective tech-transfer? Some of the major risks in a technology transfer are lack of process robustness, clear regulatory strategy and poor project management. At Recipharm we commit to quality across every aspect of your project’s technology transfer. We scale, transfer, and validate processes rapidly by harnessing effective communication, collaboration and process management that mitigate risks, comply with regulations, and uphold our track record for excellence. Trust the Recipharm team to deliver a seamless tech-transfer each and every time. Find out more: https://lnkd.in/dNYR7fap #techtransfer #CDMO
-
WEBINAR | Listen to our expert speakers Yves Buelens, Jean-Christophe Moreau and Christophe Schwoehrer explain blow-fill-seal (BFS) technology and the unique benefits of unidose BFS for ophthalmics, biologics and other sterile drug products. Webinar learning objectives: 1. What is BFS technology and the unique benefits of unidose BFS 2. What are the advantages of BFS unidose format in comparison to ocular multidose or glass vial format? 3. How can a CDMO support pharma companies in switching to unidose BFS Watch on demand: https://lnkd.in/d9TRp6ZV
-
Interest in mRNA technology is higher than ever. However, there are challenges and production bottlenecks that make the scale-up of current mRNA technologies difficult. Could the development of continuous mRNA manufacturing hold the key? In a recent article for DCAT® Value Chain Insights, ReciBioPharm’s Chief Scientific Officer, Aaron B Cowley , explains how ReciBioPharm is working with MIT’s Center for Continuous mRNA Manufacturing to, in his own words, “advance RNA manufacturing far beyond what exists today in the realm of intelligent manufacturing”. Read on to find out more: https://lnkd.in/dY8YyMmD #ContinuousmRNAManufacturing #mRNA #ATMP #MIT #CenterForContinuousmRNAManufacturing
Liknande sidor
Finansiering
Senaste finansieringsrunda
Aktiekapital efter börsintroduktion32 000 000,00 US$